Labcorp Investing Activities - Other 2010-2025 | LH
Labcorp annual/quarterly investing activities - other history and growth rate from 2010 to 2025. Investing activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the investing activities section of the Cash Flows Statement
- Labcorp investing activities - other for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
- Labcorp investing activities - other for the twelve months ending March 31, 2025 was $0M, a 100% decline year-over-year.
- Labcorp annual investing activities - other for 2024 was $0B, a 100% decline from 2023.
- Labcorp annual investing activities - other for 2023 was $-0.025B, a 50.3% decline from 2022.
- Labcorp annual investing activities - other for 2022 was $-0.05B, a 27.76% increase from 2021.
Labcorp Annual Investing Activities - Other
(Millions of US $) |
| 2024 |
$N/A |
| 2023 |
$-25 |
| 2022 |
$-50 |
| 2021 |
$-39 |
| 2020 |
$4 |
| 2019 |
$11 |
| 2018 |
$18 |
| 2017 |
$N/A |
| 2016 |
$N/A |
| 2015 |
$N/A |
| 2014 |
$N/A |
| 2013 |
$N/A |
| 2012 |
$N/A |
| 2011 |
$N/A |
| 2010 |
$N/A |
| 2009 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$20.885B |
$13.009B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
